Table 2 Summary of included studies
Study name | Country | Cause | Age (mean/range) | Sample size |
|---|---|---|---|---|
Pardo (2020) [9] | Colombia | Congenital nasal pyriform aperture stenosis (CNPAS) | Neonates | 13 |
Reeves (2013) [10] | USA | Congenital nasal piriform aperture stenosis (CNPAS) | Neonates (< 30 days old) | 13 |
Levi (2020) [11] | Israel | Congenital midnasal stenosis | Neonates (birth to 3 months) | 9 |
Patel (2017) [12] | USA | Congenital nasal obstruction in neonates | Neonates | 34 |
Cavazza (2008) [13] | Italy | Congenital dacryocystocele | Neonates (7 to 60 days) | 5 |
Benoit (2008) [14] | USA | Cancer of nasal cavity | 7 months to 17 years | 16 |
Weber (2017) [15] | Brazil | Nasal polyposis (in cystic fibrosis) | 3 to 16 years | 23 |
Manole (2014) [16] | Romania | Chronic rhinosinusitis (in asthmatic children) | 4 to 12 years | 248 |
Liu (2014) [17] | China | Nasopharyngeal carcinoma | 62.5 months | 158 |
PoddÄ (2019) [18] | Poland | Adenoid hypertrophy | 7 to 12 years | NR |
Giron (2017) [19] | Guatemala | Juvenile nasopharyngeal angiofibroma (JNPAF) | 8 to 17 years | 350 |
Zheng (2019) [20] | China | Antrochoanal polyps (ACPs) | 9 (8 to 11) years | 43 |
Kasprzyk (2017) [21] | Poland | Antrochoanal polyp (ACP) | 9 to 16 years | 15 |
Sobol (2016) [22] | USA | Cleft lip and palate | 9 to 17 years | 176 |
Zhang (2018) [23] | USA | Cleft lip and palate | 9.8 years | 63 |
Zhang (2019) [24] | USA | Cleft lip and palate | 10 years | 1028 |
Crealey (2018) [25] | Ireland | Allergic rhinitis (in asthmatic children) | Not reported | 89 |
Abdel-Aziz (2017) [26] | Egypt | Maxillary sinus mucocele (MSM) | 15 to 52 years | 36 |
Venkatramani (2016) [27] | USA | Esthesioneuroblastoma (ENB) | 14 (0.6 to 20) years | 24 |
Brennan (2006) [28] | UK | Nasopharyngeal carcinoma (NPC) | 0 to 18 years | NR |